Cargando…

Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study

OBJECTIVES: This study evaluated the effectiveness of a structured multidisciplinary risk assessment and management programme for patients with hypertension (RAMP-HT) who were managed in public primary care clinics but had suboptimal blood pressure (BP) control in improving BP, LDL-cholesterol (LDL-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Esther Y.T., Wan, Eric Y.F., Wong, Carlos K.H., Chan, Anca K.C., Chan, Karina H.Y., Ho, Sin-yi, Kwok, Ruby L.P., Lam, Cindy L.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	ORIGINAL PAPERS: Therapeutic aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278886/ https://www.ncbi.nlm.nih.gov/pubmed/27861244 http://dx.doi.org/10.1097/HJH.0000000000001177

Ejemplares similares

Clinical and patient‐reported outcomes of Chinese patients undergoing haemodialysis in hospital or in the community: A 1‐year longitudinal study
por: Chen, Julie Y, et al.
Publicado: (2016)

Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing
por: Wong, Carlos KH, et al.
Publicado: (2015)

DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control
por: Wong, Carlos K H, et al.
Publicado: (2020)

Increased number of structured diabetes education attendance was not associated with the improvement in patient-reported health-related quality of life: results from Patient Empowerment Programme (PEP)
por: Wong, Carlos K.H., et al.
Publicado: (2015)

Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients
por: Fung, Colman SC, et al.
Publicado: (2012)

The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cells
por: Leung, T H-Y, et al.
Publicado: (2013)

Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
por: Yuen, H-F, et al.
Publicado: (2010)

Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes
por: White, William B., et al.
Publicado: (2016)

Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study
por: Cremers, Anne L., et al.
Publicado: (2019)

More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study
por: Stewart, Simon, et al.
Publicado: (2014)

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
por: Mathiassen, Ole N., et al.
Publicado: (2016)

Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015)

Evaluation of the quality of care of a haemodialysis public-private partnership programme for patients with end-stage renal disease
por: Chen, Julie Y., et al.
Publicado: (2016)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model
por: Cohen-Mazor, Meital, et al.
Publicado: (2014)

Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors
por: Kaymakcalan, M D, et al.
Publicado: (2013)

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2007)

Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro
por: Hingley-Wilson, S.M., et al.
Publicado: (2010)

Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods
por: Yam, W.C., et al.
Publicado: (2005)

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial
por: Mancia, Giuseppe, et al.
Publicado: (2014)

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy
por: Schumacher, Christoph D., et al.
Publicado: (2013)

Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012
por: Sengul, Sule, et al.
Publicado: (2016)

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Long-term effect of specific treatment of primary aldosteronism on carotid intima–media thickness
por: Holaj, Robert, et al.
Publicado: (2015)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry
por: Song, Jie, et al.
Publicado: (2016)

Effects of a nationwide strategy to reduce salt intake in Samoa
por: Trieu, Kathy, et al.
Publicado: (2018)

Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report
por: Dell’Oro, Raffaella, et al.
Publicado: (2017)

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China
por: Wang, Zengwu, et al.
Publicado: (2017)

Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension
por: Peacock, Erin, et al.
Publicado: (2021)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021)

Laminin γ1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16–F10 mouse melanoma cells
por: Kuratomi, Y, et al.
Publicado: (2002)

Cognitive toxicity of drugs used in the elderly
por: von Moltke, Lisa L., et al.
Publicado: (2001)

Evaluation of the Effectiveness of Nurse-Led Continence Care Treatments for Chinese Primary Care Patients with Lower Urinary Tract Symptoms
por: Choi, Edmond P. H., et al.
Publicado: (2015)

Validation of a risk prediction score for proximal neoplasia in colorectal cancer screening: a prospective colonoscopy study
por: Wong, Martin C.S., et al.
Publicado: (2016)

Patterns of health-related quality of life and associated factors in Chinese patients undergoing haemodialysis
por: Wan, Eric Y. F., et al.
Publicado: (2015)

Impaired cerebral blood flow in type 2 diabetes mellitus – A comparative study with subjective cognitive decline, vascular dementia and Alzheimer’s disease subjects
por: Chau, Anson C.M., et al.
Publicado: (2020)

Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice
por: Sawada, N, et al.
Publicado: (2004)

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
por: Shen, Y-C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_miqbtij6c1sbn6q9g3upkff74p